DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tezosentan is an investigational drug.
There have been 6 clinical trials for Tezosentan. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2003.
The most common disease conditions in clinical trials are Hypertension, Familial Primary Pulmonary Hypertension, and Heart Failure. The leading clinical trial sponsors are Actelion, Medical University of Vienna, and [disabled in preview].
Recent Clinical Trials for Tezosentan
|Tezosentan in Patients With Pulmonary Arterial Hypertension||Actelion||Phase 2|
|Tezosentan in Pulmonary Arterial Hypertension||Actelion||Phase 2|
|Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction||Medical University of Vienna||Phase 2|